| Literature DB >> 28993196 |
Jun Meng1, Zhenyu Yao2, Yaqing He1, Renli Zhang1, Hong Yang1, Xiangjie Yao1, Long Chen1, Hailong Zhang1, Jinquan Cheng3.
Abstract
Enterovirus 71 (EV71) is associated with the severe hand foot and mouth disease (HFMD) outcomes, however the host-virus interaction mechanism and the pathogenesis remain poorly understood. Long non-coding RNAs (lncRNAs) are involved in variety physiological and pathological processes, but the functions of lncRNAs in EV71 infection remain elusive. Here we profiled the expression of lncRNAs in peripheral blood mononuclear cells (PBMCs) from EV71-infected mild patients, severe patients as well as the healthy controls, and identified 8541 lncRNAs were differentially expressed. Focused on the dynamic changed lncRNAs, we performed systematic bioinformatics analysis with Series Test of Cluster (STC) algorithm, Gene Ontology (GO) analysis, pathway analysis and lncRNA-mRNA co-expression network analysis, and revealed the potential functions and related pathways of these lncRNAs were associated with immunity and inflammation during the clinical process of EV71-infected HFMD. Among the significant dynamic changed lncRNAs, ten lncRNAs were screened whose expression were further validated in EV71-infected mild patients, severe patients and healthy control. These results shed light on the potential roles of lncRNAs in EV71-infected HFMD, especially in distinguishing the mild and severe cases for early diagnose and treatment, moreover, provide deeper insight into the mechanism of EV71-induced immune and inflammatory responses, as well as the pathogenesis of the imbalanced inflammation in severe EV71 infection.Entities:
Keywords: Enterovirus 71; Hand foot and mouth disease; Inflammation; Innate immunity; Long non-coding RNA
Mesh:
Substances:
Year: 2017 PMID: 28993196 PMCID: PMC7092854 DOI: 10.1016/j.bbrc.2017.09.141
Source DB: PubMed Journal: Biochem Biophys Res Commun ISSN: 0006-291X Impact factor: 3.575
Fig. 1Hierarchical clustering analysis of differentially expressed genes in healthy control, mild and severe HFMD patients. (A and B) Differentially expressed lncRNAs (A) and mRNAs (B) in healthy control (n = 10), mild HFMD patients (n = 10) and severe HFMD patients (n = 12). Red and green color indicates up-regulated and down-regulated transcripts, respectively. (For interpretation of the references to colour in this figure legend, the reader is referred to the web version of this article.)
Fig. 2STC analysis of distinctive dynamic expression profiles of lncRNAs and mRNAs in severe and mild EV71-infected HFMD patients and healthy control. (A) The differentially expressed lncRNAs and mRNAs are group into 16 model pattern profiles, and 8 significantly different profiles are identified and the change trend of these profile are shown in the red box. (B) In the first 4 significant profiles, the expression change of lncRNAs in severe and mild HFMD patients and healthy control are shown. (For interpretation of the references to colour in this figure legend, the reader is referred to the web version of this article.)
Fig. 3GO enrichment analysis and KEGG pathway analysis of differentially expressed mRNAs. (A–D) The GO analysis of mRNAs in Profile 9 according to biological process, the horizontal axis represents –lg (P value) of the GO category. (E–H) The KEGG pathway analysis of mRNAs in Profile 9, the horizontal axis represents –lg (P value) of the pathway terms.
Fig. 4Co-expression network of lncRNAs-mRNAs and validation of candidate lncRNAs. (A) In Profile9, the network is consist of 92 lncRNAs and 61 correlated mRNAs with 153 network nodes and 380 connection edges, the purple node denote mRNA and the purple node around by yellow denote lncRNA. (B) Q-PCR analysis of 10 candidate lncRNAs in severe HFMD patients (n = 22), mild HFMD patients (n = 20) and healthy control (n = 20). Data are shown as mean ± S.D., **P < 0.01. (For interpretation of the references to colour in this figure legend, the reader is referred to the web version of this article.)